In vivo demonstration of pulmonary microvascular involvement in COVID-19 using dual-energy computed tomography. Issue 4 (29th October 2020)

• Record Type: Journal Article
• Authors: Si-Mohamed, Salim; Chebib, Nader; Sigovan, Monica; Zumbihl, Lea; Turquier, Ségoléne; Boccalini, Sara; Boussel, Loic; Mornex, Jean-Francois; Cottin, Vincent; Douek, Philippe
• Is Part Of: European respiratory journal. Volume 56:Issue 4(2020)
• Publication Date: 2020-10-29
• Subjects: Respiratory organs -- Diseases -- Periodicals; Respiration -- Periodicals; 616.2
• DOI: 10.1183/13993003.02608-2020
• Languages: English
• ISSNs: 0903-1936

Abstract

Vascular involvement in coronavirus disease 2019 (COVID-19) has been suggested by several observations, such as the high rate of pulmonary embolism [1], the prothrombotic state and the proinflammatory biological profile [2, 3], as well as the pathological findings of severe endothelial injury and diffuse thrombosis [4]. Dual-energy computed tomography (DECT) allows specific imaging of the iodinated contrast agent distribution within the lung, which has been demonstrated as a surrogate marker of lung perfusion [5, 6]. Therefore, our goal was to assess in vivo pulmonary microvascular involvement in patients with COVID-19 pneumonia by using DECT and to determine whether vascular changes vary during the course of the disease. In COVID-19 pneumonia, dual-energy computed tomography has shown two patterns of lung perfusion along the course of the disease: an increase in perfusion blood volume (PBV) with ground-glass opacities and a decrease in PBV with consolidation https://bit.ly/2Zh0XcI